Aqueous solutions of PbS were stored at T = 4 °C under nitrogen atmosphere. Quantum yield measurements were performed using Edinburg Instrument fluorescence spectrometer system FLS980 equipped with 120 mm diameter integrating sphere.
Synthesis of PbS QDs with DHLA-PEG400-R:
DHLA-PEG400-R (0.129 mmol), where R isOMe, -NH2, -COOH, was dissolved in water (10 ml) and the solution stirred and degassed with nitrogen for 15 minutes. Pb 2+ (0.43 mL, 0.1M of Pb(OAc)2 in water) was added and the pH was adjusted with trimethylamine (TEA) to pH = 11. Aqueous solution of Na2S was added dropwise to form the nanocrystals: in order to form the QDs of different sizes, the ratio of Pb 2+ to S 2-was varied from 1:0.3 (0.26 mL, 0.05 M Na2S) to 1:0.6 (0.52 mL, 0.05 M Na2S).
Near-infrared imaging:
A home-built second-NIR fluorescence microscope used is based on the Macro Zoom System at magnification of 0.63x (MVX; Olympus) and is equipped with an InGaAs CMOS camera (C10633-34; Hamamatsu photonics KK). A customized filter set consisting of an excitation filter for the 670 nm laser, dichroic mirror to reflect the 670 nm laser, and a band-pass emission filters (1000 ± 25 nm and 1300 ± 25 nm) was used for imaging.
670 nm laser diodes (BWF1 series; B&W TEK) were used to provide excitation light.
Maximum excitation powers on the sample stage were 25.5 mW/cm 2 . Device control and data acquisition were performed by HCImage (Hamamatsu photonics) software and a customized LabVIEW program (National Instruments). Images were processed using Fiji software.
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2-month old female BALB/c nu/nu mice (Charles River Japan) were injected with 30 L of a 0.2 mM QD solution via a tail vein. For in vivo imaging, special bait without alfalfa (Oriental yeast, Tokyo, Japan) were fed to all of mice until the onset of experiment. Experiments were conducted after one week of its feeding. Second-NIR fluorescence images (ex: 670 nm, emission > 1000 nm) of anesthetized mouse were taken immediately after injection, and 24 h and 48 h after the injection. Mice were then humanely killed and organs removed for ex vivo imaging. Liver and brain tissue from untreated mice were cut into slices of defined thicknesses between 0.1 mm and 4 mm using a microslicer (DTK-1000; Dosaka EM). Slices of different thickness were then overlaid in turn over sealed capillaries containing QD solutions at 1 mg/ml.
All experiments were performed in compliance with the National Institutes of Health MHz in CDCl3. TLCs were carried out using a 10:1 (v/v) DCM/methanol eluent.
Scheme S1 Scheme of the reactions used for ligand synthesis.
1) N3-PEG400-N3 was synthesised in a yield of 65.5 %. 2) LA-PEG400-N3 was synthesised in 71% yield. TLC Rf~ 0. (m, 2H).
All ligand molecules were synthesized under N2 atmosphere. The LA was reduced to DHLA to provide the anchoring thiol (-SH) groups. Briefly, LA-PEG400-R, where R is -NH2, COOH or OMe, was dissolved in water/ethanol (5 mL, 4:1 v/v) and sodium borohydride (4 eq.) was added to the solution. After 4 h stirring, brine (10 mL) was added to quench the reaction and the product was extracted with chloroform (5x 20 mL). The analysis of the resulting products is given below.
DHLA-PEG400-OMe ( Figure S1 . The changes observed over 48 h of the ligand in solution by NMR are shown in Figure S2 and the corresponding kinetic parameters are summarised in the Table S1 . We attribute the colloidal instability of QDs synthesized using these molecules as capping ligands to oxidation of the DHLA portion of the ligand molecule and to the presence of phosphine and phosphine oxides from the Staudinger reduction of the azide groups. The presence of phosphine oxides in the ligand solution is confirmed by 31 P NMR ( Figure S3 ).
Binding of phosphine oxides to the nanocrystals surface makes it hydrophobic, thus leading to their precipitation from the aqueous solution. 
SI3 Tissue penetration studies, in vitro cytotoxicity and in vivo imaging
In order to assess the potential of DHLA-PEG capped PbS QDs for bioimaging applications, we have prepared mouse brain and liver tissue slices with thickness varying from 0.2 mm to 4 mm. The slices were placed over ~1 mm diameter glass capillaries containing LNH2 QD solutions with photoluminescence centered at 1050 nm and at 1200 nm and they were then imaged ( Figure S4 ). Liver Figure S5 shows the MTT profile for three studies cell lines exposed to PbS-LNH2 QDs over a period of 72h.
Figure S5
In vitro assessment of cytotoxicity of PbS-LNH2 QDs using MTT assay.
Immediately following injection of QD solutions via tail vein, the NIR imaging of mice revealed emission in was observed in internal veins ~ 0.5 -1 cm below the skin/skull as well as facial veins/capillaries closer to the surface ( Figure S6 ). No measureable emission was observed in brain after ~ 30 sec after injection. Average Cell Viability (%)
Concentration (g/ml) Figure S7 shows typical photoluminescence images of control mouse and that injected with the QD solution. The photoluminescence was detected only in QD-injected mice, and was observed in the areas of liver and spleen and in corresponding organs ex-vivo. In some QDinjected mice we also observed NIR light emission in the bladder area ( Figure S8 ), suggesting that QDs are cleared from the body via the urinary tract. 
